Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1186
| Despition | Olig2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1067 | Recombinant Human CD11b Protein (Fc Tag) (AC1067) | 50 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1547 | Human CA14 Protein (AC1547) | 5 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1319 | Axin 2 Blocking Peptide (AC1319) | 250 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.